Building an extensive portfolio of RFID pre-tagged medications.
+RFID® is a portfolio of RFID-enabled, pre-tagged medications manufactured by Fresenius Kabi. Launched in 2020, the portfolio supports a safer and more efficient inventory process for hospital pharmacies.
Brand Identity Development
Multiple created the +RFID brand and a system of materials to launch the new portfolio and its first product into the market. Backed by research and insights, Multiple developed key messaging to communicate why +RFID is a worthwhile investment. Through journal ads and educational materials, customers are driven to a custom microsite for more information about RFID-enabled products.


The +RFID identity was developed to work across a broad range of sizes and applications, from digital screens to small, printed product labels.


Responsive Website Design
Multiple developed a responsive microsite with animated illustrations to further explain how the +RFID Smart Labels arrive ready-to-read, which saves time and supports a safe, more efficient medication inventory process.



Marketing Campaign
A launch strategy was created to raise awareness for the new +RFID portfolio through a system of brand materials that can be updated and reused as additional products become available. Multiple continues to support the +RFID brand’s annual marketing strategy and product launches.





